doxifluridine has been researched along with Carcinoma, Epidermoid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KP; Chang, YS; Chen, CC; Chen, LC; Hseuh, C; Liang, Y; Wu, CS | 1 |
| Hasegawa, K; Kato, R; Kawamura, K; Kobayashi, Y; Okamoto, H; Sekiya, T; Udagawa, Y | 1 |
| Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Sawamura, T; Takeda, Y; Takeno, A; Tsujinaka, T | 1 |
| Abele, R; Cavalli, F; Grossenbacher, R; Kaplan, E; Schmid, HJ | 1 |
| Hasegawa, K; Hasuo, Y; Hatae, M; Honjo, H; Kobashi, Y; Kudo, T; Mizutani, K; Nishimura, R; Noda, K; Ochiai, K; Onishi, Y; Ozaki, M; Sasaki, H; Sato, S; Sugiyama, T; Terashima, Y; Yajima, A; Yakushiji, M; Yamamoto, K; Yamamoto, T | 1 |
| Ekimoto, H; Mashiba, H; Matsumoto, S; Okamoto, K | 1 |
| Ikeda, M; Noda, K; Ochiai, K; Saito, Y; Sato, A; Suzuki, M; Takada, M; Terashima, Y; Yajima, A; Yoshida, K | 1 |
| Fukuoka, H; Fukushima, S; Hosaka, M; Kinoshita, Y; Kondo, I; Kubota, Y; Miura, T; Miyai, K; Moriyama, M; Shuin, T | 1 |
| Kaneda, T; Kasuya, Y; Matsuyama, M; Shinoda, T; Tohnai, I; Zhao, L | 1 |
| Calcanis, A; Drings, P | 1 |
1 review(s) available for doxifluridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Floxuridine; Fluorouracil; Humans; Lymphatic Metastasis; Middle Aged; Radiotherapy, Adjuvant; Tegafur; Uracil | 2004 |
1 trial(s) available for doxifluridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer].
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Humans; Immunotherapy; Middle Aged; Pilot Projects; Sizofiran; Uterine Cervical Neoplasms | 1998 |
8 other study(ies) available for doxifluridine and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Female; Floxuridine; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Male; Middle Aged; Mouth Neoplasms; Prognosis; Retrospective Studies; Thymidine Phosphorylase | 2012 |
The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Floxuridine; Fluorouracil; Humans; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Organoplatinum Compounds; Peplomycin; Thymidine Phosphorylase; Uterine Cervical Neoplasms | 2012 |
Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck.
Topics: Aged; Antineoplastic Agents; Bone Marrow Diseases; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Head and Neck Neoplasms; Humans; Male; Middle Aged | 1984 |
[Evaluation of antitumor activity of etoposide administered orally for 21 consecutive days against human uterine cancer subcutaneous and/or orthotopic xenografts in nude mice].
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Floxuridine; Humans; Irinotecan; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Skin; Transplantation, Heterologous; Uterine Neoplasms | 1999 |
[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Humans; Middle Aged; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1991 |
[Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Diarrhea; Drug Administration Schedule; Drug Evaluation; Female; Floxuridine; Humans; Male; Middle Aged; Nausea; Urinary Bladder Neoplasms | 1991 |
[Experimental study relating to the anti-cancer effect of doxifluridine].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Female; Floxuridine; Methylcholanthrene; Mice; Mice, Inbred Strains; Skin Neoplasms | 1990 |
[Furtulon (doxifluridine) in the treatment of non-small cell bronchial carcinoma].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Floxuridine; Humans; Lung Neoplasms; Male; Middle Aged | 1987 |